Pre hearing information
The tribunal will inquire into the allegation that between January 2007 and July 2015 Dr Kerrane enrolled ineligible patients into clinical trials that he conducted on behalf of Novartis Pharmaceuticals UK Limited. The tribunal will also inquire into the allegation that Dr Kerrane acted dishonestly by, amongst other things, retrospectively amending medical records regarding patients involved in the clinical trials and asking for payment for one trial to be made into his personal bank account when he knew it should be paid into Fylde Coast Clinical Research’s bank account.
This reflects the allegation as it stands at the start of the hearing. The allegation may be amended as the hearing proceeds and when findings of fact are made by the tribunal.
All decisions are published online within 28 days of the conclusion of the hearing.
If you're a journalist and need up to date information about the allegation throughout the course of the hearing, please contact our press office at email@example.com or call 0161 250 6868.
In accordance with Rule 41(2) of the General Medical Council (Fitness to Practise) Rules 2004, the tribunal may decide to exclude the public from the proceedings or any part of the proceedings, where they consider that the circumstances of the case outweigh the public interest in holding the hearing in public.